Cricket is set to undergo another big change as some of the big names from the cricketing world have come together to announce a new format: Test Twenty. This will be another evolution in the game ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

What rules does the Trump administration’s new naturalization test change regarding the questions immigrants must answer? The U.S. Citizenship and Immigration Services (USCIS) issued an alert on ...

Take our RMD quiz to test your retirement tax knowledge. Learn about RMD rules, IRS deadlines, and tax penalties that could ...

Cricket's 'next chapter' has begun, with the unveiling of its fourth format – Test Twenty. As the name suggests, it blends "Test strategy with T20 intensity", and is the world's first 80-over format.

Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. - Sarah Silbiger/Getty Images The US Food and Drug Administration has ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer's disease and other causes of cognitive decline, providing a broader understanding of when the ...

A new blood test could speed up diagnosis and treatment for people dealing with early memory or thinking changes. The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to ...

The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease and other cognitive issues when they have the symptoms of the conditions. It ...

A blood test that could help rule out Alzheimer's is now cleared by the FDA. The test is designed for adults 55 and up who are displaying early signs of cognitive decline. Joining us to talk about ...